Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Carcinoma, Nasopharyngeal”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Looking for participantsNCT06532279
What this trial is testing

Testing the Addition of the Drug BMX-001, a Radioprotector, or a Placebo to the Usual Chemoradiation Therapy for Patients With Head and Neck Cancer

Who this might be right for
Clinical Stage I HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8Clinical Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8+38 more
NRG Oncology 98
Early research (Phase 1)Study completedNCT00470496
What this trial is testing

Photodynamic Therapy Using HPPH in Treating Patients Undergoing Surgery for Primary or Recurrent Head and Neck Cancer

Who this might be right for
Recurrent Adenoid Cystic Carcinoma of the Oral CavityRecurrent Basal Cell Carcinoma of the LipRecurrent Esthesioneuroblastoma of the Paranasal Sinus and Nasal Cavity+52 more
Roswell Park Cancer Institute 15
Testing effectiveness (Phase 2)Study completedNCT00228488
What this trial is testing

Effect of Iressa With/Without Concurrent Chemoradiotherapy on Tumor Gene Expression Profiles in Patients With Advanced Non-Nasopharyngeal Head and Neck Carcinoma

Who this might be right for
Head and Neck Cancer
AstraZeneca 60
Testing effectiveness (Phase 2)Ended earlyNCT02569788
What this trial is testing

Trail Evaluating Carbon Ion Radiotherapy for Locally Recurrent Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Carcinoma
Shanghai Proton and Heavy Ion Center 9
Testing effectiveness (Phase 2)UnknownNCT04015661
What this trial is testing

Induction Chemotherapy Followed by Concurrent Chemoradiotherapy in Patients With LA-NPC

Who this might be right for
Nasopharyngeal Carcinoma
Fuzhou General Hospital 92
Not applicableStudy completedNCT01194635
What this trial is testing

Biomarkers of Response in Blood and Tumor Tissue Samples From Patients With Unresectable Stage IV Squamous Cell Cancer of the Head and Neck Previously Treated With Cetuximab, Cisplatin, and Radiation Therapy

Who this might be right for
Head and Neck Cancer
ECOG-ACRIN Cancer Research Group 69
Testing effectiveness (Phase 2)Study completedNCT00448552
What this trial is testing

Oxaliplatin and Capecitabine in Treating Patients With Relapsed or Metastatic Head and Neck Cancer

Who this might be right for
Head and Neck Cancer
University of Miami 30
Large-scale testing (Phase 3)Looking for participantsNCT04453826
What this trial is testing

Concurrent and Adjuvant PD1 Treatment Combined With Chemo-radiotherapy for High-risk Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal CancerChemotherapyRadiotherapy+1 more
Sun Yat-sen University 388
Early research (Phase 1)Study completedNCT04945421
What this trial is testing

IBI310 in Combination With Siltilimab in Subjects With Anti-PD-1/PD-L1 Resistance R/M NPC

Who this might be right for
NPC
Innovent Biologics (Suzhou) Co. Ltd. 30
Not applicableUnknownNCT01171235
What this trial is testing

Study of Biomarker From Blood and Tissue of Head and Neck Carcinoma

Who this might be right for
Laryngeal NeoplasmsPharyngeal Neoplasms
Southern Medical University, China 200
Testing effectiveness (Phase 2)UnknownNCT04769076
What this trial is testing

The Paclitaxel (Albumin-bound) Combined With Cisplatin, PD-1 Inhibitors and IMRT in the Treatment of Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Carcinoma
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School 40
Large-scale testing (Phase 3)Looking for participantsNCT07177443
What this trial is testing

Serplulimab Combined With Induction Chemotherapy and Radiotherapy in Nasopharyngeal Carcinoma

Who this might be right for
Locally Advanced Nasopharyngeal Carcinoma
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 710
Not applicableStudy completedNCT03429868
What this trial is testing

PET and MRI in Prognosis Prediction of NPC

Who this might be right for
Nasopharyngeal Carcinoma
Chang Gung Memorial Hospital 180
Early research (Phase 1)UnknownNCT03282617
What this trial is testing

Dendritic Cell Therapy With CD137L-DC-EBV-VAX in Locally Advanced Stage IV or Locally Recurrent/Metastatic Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Cancer
National University Hospital, Singapore 55
Large-scale testing (Phase 3)UnknownNCT03720340
What this trial is testing

Interleukin-11 Can Prevent and Treat of Radioactive Oral Mucitis

Who this might be right for
Nasopharyngeal Carcinoma
Zhejiang Cancer Hospital 300
Large-scale testing (Phase 3)UnknownNCT03006588
What this trial is testing

EUS-FNA for Retropharyngeal Lymph Node (RPLN) in Recurrent Nasopharyngeal Carcinoma (NPC) Patients

Who this might be right for
Nasopharyngeal Carcinoma
Sun Yat-sen University 100
Large-scale testing (Phase 3)Study completedNCT03581786
What this trial is testing

The Efficacy and Safety Study of TORIPALIMAB INJECTION Combined With Chemotherapy for Nasophapyngeal Cancer

Who this might be right for
Recurrent or Metastatic NPC
Shanghai Junshi Bioscience Co., Ltd. 289
Testing effectiveness (Phase 2)Study completedNCT00055770
What this trial is testing

Erlotinib Plus Docetaxel in Treating Patients With Locally Advanced, Metastatic, or Recurrent Head and Neck Cancer

Who this might be right for
Recurrent Salivary Gland CancerRecurrent Squamous Cell Carcinoma of the HypopharynxRecurrent Squamous Cell Carcinoma of the Larynx+19 more
National Cancer Institute (NCI) 45
Testing effectiveness (Phase 2)Ended earlyNCT00503776
What this trial is testing

Chemo/XRT +/- Amifostine to Assess Outcomes Related to Xerostomia, Mucositis, & Dysphagia

Who this might be right for
DysphagiaHead and Neck CancerMucositis+1 more
Vanderbilt-Ingram Cancer Center 41
Not applicableUnknownNCT01254591
What this trial is testing

Positron Emission Tomography/Computed Tomography Scanning Before Surgery in Patients With Non-Small Cell Lung Cancer, Colorectal Cancer, Breast Cancer, Esophageal Cancer, or Head and Neck Cancer

Who this might be right for
Breast CancerColorectal CancerEsophageal Cancer+2 more
University College London (UCL) Cancer Institute 500
Next Page